A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)

被引：13

作者：

Gargiulo, L. ^{[1
,2
,22
]}

Ibba, L. ^{[1
,2
]}

Malagoli, P. ^{[3
]}

Amoruso, F. ^{[4
]}

Argenziano, G. ^{[5
]}

Balato, A. ^{[5
]}

Bardazzi, F. ^{[6
]}

Burlando, M. ^{[7
]}

Carrera, C. G. ^{[8
]}

Damiani, G. ^{[9
,10
]}

Dapavo, P. ^{[11
]}

Dini, V. ^{[12
]}

Fabbrocini, G. ^{[13
]}

Franchi, C. ^{[10
]}

Gaiani, F. M. ^{[3
]}

Girolomoni, G. ^{[14
]}

Guarneri, C. ^{[15
]}

Lasagni, C. ^{[16
]}

Loconsole, F. ^{[17
]}

Marzano, A. V. ^{[8
,18
]}

Maurelli, M. ^{[14
]}

Megna, M. ^{[13
]}

Orsini, D. ^{[19
]}

Sampogna, F. ^{[20
]}

Travaglini, M. ^{[21
]}

Valenti, M. ^{[1
,2
,13
]}

Costanzo, A. ^{[1
,2
]}

Narcisi, A. ^{[1
]}

机构：

[1] IRCCS Humanitas Res Hosp, Dermatol Unit, Milan, Italy

[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[3] Azienda Osped San Donato Milanese, Dept Dermatol, Dermatol Unit, Milan, Italy

[4] Azienda Osped Cosenza, Dermatol Unit, Cosenza, Italy

[5] Univ Campania L Vanvitelli, Dermatol Unit, Naples, Italy

[6] IRCCS Azienda Osped Univ Bologna, Dermatol Unit, Policlin S Orsola Malpighi, Bologna, Italy

[7] Univ Genoa, IRCCS Osped Policlin San Martino, Dept Dermatol, Dipartimento Sci Salute DISSAL, Genoa, Italy

[8] Fdn IRCCS Cagranda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy

[9] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy

[10] IRCCS Osped Galeazzi St Ambrogio, Clin Dermatol, Milan, Italy

[11] Univ Turin, Dept Biomed Sci & Human Oncol, Dermatol Clin 2, Turin, Italy

[12] Osped Santa Chiara, Dept Clin & Expt Med, Dermatol Unit, Pisa, Italy

[13] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy

[14] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy

[15] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Unit Dermatol, AOU Policlin G Martino, Messina, Italy

[16] Univ Modena, Dept Specialized Med, Dermatol Clin, Modena, Italy

[17] Univ Bari, Dept Dermatol, Bari, Italy

[18] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[19] IRCCS, UOC Clin Dermatol Dermatol Inst S Gallicano, Rome, Italy

[20] Ist Dermopat Immacolata IDI IRCCS, Clin Epidemiol Unit, Rome, Italy

[21] UOSD Dermatol Ctr Cura Psoriasi, Brindisi, Italy

[22] Humanitas Univ, Dept Biomed Sci, I-20089 Milan, Italy

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2024年 / 38卷 / 01期

关键词：

D O I：

10.1111/jdv.19464

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E113 / E116

页数：4

共 10 条

[1] Risankizumab Therapy for Moderate-to-Severe Psoriasis-A Multi-Center, Long-Term, Real-Life Study from Poland [J].

Adamczyk, Michal ;

Bartosinska, Joanna ;

Raczkiewicz, Dorota ;

Adamska, Kinga ;

Adamski, Zygmunt ;

Czubek, Maria ;

Krecisz, Beata ;

Klujszo, Elzbieta ;

Lesiak, Aleksandra ;

Narbutt, Joanna ;

Noweta, Marcin ;

Owczarczyk-Saczonek, Agnieszka ;

Owczarek, Witold ;

Reich, Adam ;

Samotij, Dominik ;

Siekierko, Aleksandra ;

Szczech, Justyna ;

Walecka, Irena ;

Ciechanowicz, Piotr ;

Wozniacka, Anna ;

Liszewska, Agata ;

Krasowska, Dorota .

JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)

[2] Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population [J].

Augustin, M. ;

Dauden, E. ;

Mrowietz, U. ;

Konstantinou, M. P. ;

Gerdes, S. ;

Rissler, M. ;

Gathmann, S. ;

Sieder, C. ;

Baeumer, D. ;

Orsenigo, R. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (11) :2548-2556

[3] Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS) [J].

Gargiulo, Luigi ;

Ibba, Luciano ;

Malagoli, Piergiorgio ;

Angileri, Rosa Giuseppa ;

Bardazzi, Federico ;

Bernardini, Nicoletta ;

Burlando, Martina ;

Carrera, Carlo G. ;

Chiricozzi, Andrea ;

Dapavo, Paolo ;

Dini, Valentina ;

Fabbrocini, Gabriella ;

Gaiani, Francesca Maria ;

Galluzzo, Marco ;

Giofre, Claudia ;

Guarneri, Claudio ;

Loconsole, Francesco ;

Malara, Giovanna ;

Marcelli, Lorenzo ;

Megna, Matteo ;

Piaserico, Stefano ;

Talamonti, Marina ;

Costanzo, Antonio ;

Narcisi, Alessandra .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (05) :1017-1027

[4] Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study [J].

Gargiulo, Luigi ;

Ibba, Luciano ;

Pavia, Giulia ;

Vignoli, Carlo Alberto ;

Piscazzi, Francesco ;

Valenti, Mario ;

Sanna, Federica ;

Perugini, Chiara ;

Avagliano, Jessica ;

Costanzo, Antonio ;

Narcisi, Alessandra .

DERMATOLOGY AND THERAPY, 2022, 12 (10) :2309-2324

[5] Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis [J].

Gisondi, Paolo ;

Fargnoli, Maria C. ;

Amerio, Paolo ;

Argenziano, Giuseppe ;

Bardazzi, Federico ;

Bianchi, Luca ;

Chiricozzi, Andrea ;

Conti, Andrea ;

Corazza, Monica ;

Costanzo, Antonio ;

Dapavo, Paolo ;

De Simone, Clara ;

Fabbrocini, Gabriella ;

Feliciani, Claudio ;

Foti, Caterina ;

Girolomoni, Giampiero ;

Guarneri, Claudio ;

Marzano, Angelo V. ;

Micali, Giuseppe ;

Offidani, Annamaria ;

Parodi, Aurora ;

Pellacani, Giovanni ;

Piaserico, Stefano ;

Prignano, Francesca ;

Romanelli, Marco ;

Rongioletti, Franco ;

Rubegni, Pietro ;

Stinco, Giuseppe ;

Stingeni, Luca ;

Tomasini, Carlo F. ;

Venturini, Marina ;

Peris, Ketty ;

Calzavara-Pinton, Piergiacomo .

ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2022, 157 :1-+

[6] Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic [J].

Gkalpakiotis, Spyridon ;

Cetkovska, Petra ;

Arenberger, Petr ;

Dolezal, Tomas ;

Arenbergerova, Monika ;

Velackova, Barbora ;

Fialova, Jorga ;

Kojanova, Martina .

DERMATOLOGY AND THERAPY, 2021, 11 (04) :1345-1355

[7] Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials [J].

Gordon, Kenneth B. ;

Strober, Bruce ;

Lebwohl, Mark ;

Augustin, Matthias ;

Blauvelt, Andrew ;

Poulin, Yves ;

Papp, Kim A. ;

Sofen, Howard ;

Puig, Lluis ;

Foley, Peter ;

Ohtsuki, Mamitaro ;

Flack, Mary ;

Geng, Ziqian ;

Gu, Yihua ;

Valdes, Joaquin M. ;

Thompson, Elizabeth H. Z. ;

Bachelez, Herve .

LANCET, 2018, 392 (10148) :650-661

[8] Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter" [J].

Murgia, Giulia ;

Maronese, Carlo Alberto ;

Carrera, Carlo Giovanni ;

Cattaneo, Angelo ;

Marzano, Angelo Valerio .

DERMATOLOGIC THERAPY, 2022, 35 (08)

[9] Effectiveness of risankizumab in plaque psoriasis with involvement of difficultto-treat areas: a real-world experience from two referral centers [J].

Orsini, Diego ;

Gargiulo, Luigi ;

Ibba, Luciano ;

Ingurgio, Ruggero Cascio ;

Valenti, Mario ;

Perugini, Chiara ;

Pacifico, Alessia ;

Maramao, Fabio S. ;

Frascione, Pasquale ;

Costanzo, Antonio ;

Narcisi, Alessandra .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)

[10] Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study [J].

Schaekel, K. ;

Reich, K. ;

Asadullah, K. ;

Pinter, A. ;

Jullien, D. ;

Weisenseel, P. ;

Paul, C. ;

Gomez, M. ;

Wegner, S. ;

Personke, Y. ;

Kreimendahl, F. ;

Chen, Y. ;

Angsana, J. ;

Leung, M. W. L. ;

Eyerich, K. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) :2016-2027

← 1 →